START Center

Name

START Center

Legal name

South Texas Accelerated Research Therapeutics, LP

Website

https://startresearch.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

251–500 employees

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)

SIC

Services-Health Services (8000), Services-Hospitals (8060), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industries

Medical Oncology (HLAKAFAB), Oncology & Cancer Specialty Hospitals (HLAFAHAC)

Keywords

• Early phase oncology trials
• Clinical research services
• Phase I oncology studies
• Clinical trial site network
• Community oncology research

Headquarters

HQ city

San Antonio

HQ country

United States

HQ region

North America

Offices15 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Clinical Trial Services for Pharma Sponsors: START generates revenue by providing early-phase oncology clinical trial services to biopharmaceutical companies and CROs. Services include site management, patient enrollment, data management, pharmacokinetics lab services, and regulatory support. Revenue is derived from clinical trial agreements with pharma sponsors who pay for research site access and study conduct services.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

START Center for Cancer Research operates a global network of 15 dedicated early-phase (Phase I) oncology research sites across the United States and Europe, delivering end-to-end clinical trial services—including protocol design support, patient enrollment, pharmacokinetics, investigational drug services, regulatory affairs, and data management—to biopharmaceutical sponsors and CROs. The organization embeds academic medical center-grade investigators in community oncology settings to expand trial access for the 80% of cancer patients treated outside academic centers.

Product overview

START Center for Cancer Research operates as a global network of 15 dedicated early-phase oncology research sites across the United States and Europe—the world's only fully community-based early phase research organization. The core offering is the START Clinical Trial Network, which provides biopharma sponsors and CROs with access to a unified network of research sites, 40+ principal investigators, and over 1,000 active clinical trials. This is complemented by the Hope Hub, a patient-facing platform for trial discovery and enrollment navigation, and specialized services including pharmacokinetics, investigational drug services, regulatory affairs, and data management. Additionally, START offers partnership programs including the Partners in Hope patient advocacy program and a turn-key early phase research unit model for hospitals and oncology practices seeking to embed clinical trial capabilities.

Differentiator

Problem solved

Functional benefit

Products and services

• START Clinical Trial Network A global network of 15 early-phase oncology research sites across the United States and Europe, providing comprehensive Phase I clinical trial services to biopharma sponsors and CROs with a single point of contact and centralized contract, budget, and IRB review.
• Hope Hub

Quantifiable outcome

• 95% first-site enrollment rate — START is the first site to open across 95% of studies they work on
• +4 more outcomes

Named customers10 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

16 partnerships are on record, tiered core.

• Baptist Health South FloridacoreStrategic or Co-development PartnerStrategic partnership announced to expand patient access to early-phase cancer trials. The partnership leverages Baptist Health South Florida's patient population and healthcare infrastructure combined with START's clinical trial capabilities and global network.
• Livestrong FoundationcoreGTM or Marketing PartnerPartners in Hope program partner bringing clinical trial options, education, and awareness to patient communities. Co-marketing campaigns, logo placement on START Hope Hub, joint outreach and social amplification.
• Happy Lungs ProjectcoreGTM or Marketing PartnerPartners in Hope program partner dedicated to lung cancer patient advocacy. Joint education and outreach efforts to connect lung cancer patients with early-phase clinical trial options.
• CLL SocietycoreGTM or Marketing PartnerPartners in Hope program partner focused on Chronic Lymphocytic Leukemia. Collaborates on education, patient navigation, and awareness campaigns.
• Cholangiocarcinoma FoundationcoreGTM or Marketing PartnerPartners in Hope program partner for cholangiocarcinoma (bile duct cancer) patient advocacy. Provides patient education and navigation support.
• HPV Cancer AlliancecoreGTM or Marketing PartnerPartners in Hope program partner for HPV-related cancer awareness and patient support. Joint outreach and education efforts.
• Northwell HealthcoreStrategic or Co-development PartnerStrategic partnership for START New York-Long Island site. START facility is located inside Northwell's R.J. Zuckerberg Cancer Center, which is home to hundreds of Northwell Cancer Institute specialists, treatment centers, diagnostic imaging and laboratory facilities.
• Astera Cancer CarecoreStrategic or Co-development PartnerPartnership for START New Jersey location. Astera Cancer Care provides community-based care model; START provides global research excellence and early-phase oncology trial capabilities.
• OneOncologycoreStrategic or Co-development PartnerPartnership through which START Dallas Fort Worth and START Los Angeles are embedded within OneOncology's community oncology network, expanding access to early-phase clinical trials.
• The Center for Cancer and Blood Disorders (CCBD)coreStrategic or Co-development PartnerCCBD's network serves over 14,000 new patients annually. START Dallas Fort Worth is located within CCBD's network, enabling expanded access to clinical trials for patients across all major disease areas including hematologic malignancies.
• Los Angeles Cancer Network (LACN)coreStrategic or Co-development PartnerSTART Los Angeles is embedded within LACN's large community-based oncology network that serves more than 14,000 new patients annually, expanding access to clinical trials across a wide range of solid tumors and hematologic malignancies.
• South Texas Oncology & HematologycoreStrategic or Co-development PartnerCommunity partner at START San Antonio location, serving 500 new cancer patients per year. Provides the community setting for START's clinical research operations.
• Utah Cancer SpecialistscoreStrategic or Co-development PartnerCommunity partner at START Mountain Region. Utah Cancer Specialists serves the entire intermountain region and is the only dedicated community-based early phase trial site in Utah.
• Centro Hospitalar Universitario Lisboa Norte (CHLN)coreStrategic or Co-development PartnerCollaboration with Hospital de Santa Maria for START Lisbon location, filling a crucial gap in clinical research in Portugal. Previously no dedicated early phase unit existed in the region.
• Mater Misericordiae University HospitalcoreStrategic or Co-development PartnerCollaboration for START Dublin location, representing the first dedicated early phase center in the Republic of Ireland.
• University College DublincoreStrategic or Co-development PartnerAcademic partner for START Dublin location, contributing to the advancement of early-phase oncology research in Ireland.

Scale indicators14 records

Recent moves6 records

Expansion highlights6 records

Market position

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/TheSTARTCenter
• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/the-start-center-for-cancer-research

Revenue estimate

Valuation estimate

Number of profiles

Profiles15 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about START Center